Filed before 2025Filed 1 May 2018
Vivace Therapeutics, Inc. has sold $8M so far
Vivace Therapeutics, Inc., a biotech company based in San Mateo, CA, has sold $8M so far in its equity round, according to a filing dated 1 May 2018.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 1 May 2018
- First filed
- 18 May 2017
- Round
- Equity round (amended filing)
- Amount sold
- $8M
- Offering size
- $25M
- Investors so far
- 6
- Based in
- San Mateo, CA
- Website
- vivacetherapeutics.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 57% of the 1,729 tracked raises with an amount filed in 2018, and than 40% of the 160 in biotech.
Vivace Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 12 Mar 2025 | New filing | $17.5M | Another raise |
| 23 Dec 2020 | New filing | $30M | Another raise |
| 1 May 2018 | Amended filing | $8M | This raise |
| 18 May 2017 | New filing | $8M | This raise |
| 20 Jan 2015 | New filing | $5.05M | Another raise |
More with 6 Dimensions Capital on the board
- Plexium, Inc.$60.1M
- Eikon Therapeutics, Inc.$351M
- Seranova Bio, Inc.$10M
- Fog Pharmaceuticals, Inc.$23.3M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.